-
EntrepreneurIMEX USA
-
EntrepreneurInfinityBit InfinityBit: A New Era of Transparent Trading
-
EntrepreneurCreative BioTherapeutics WE START WHERE OTHER THERAPIES FAIL FOR RECURRENT & DRUG RESISTANT CANCERS
-
EntrepreneurSmart Biometric Technology
-
EntrepreneurZagreus Systems
-
EntrepreneurUbiq
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
Information
iCFO Information Booth How can we help? -
Entrepreneur
TrainingLab TrainingLab trains employees in soft skills using AI-powered characters in virtual reality
-
Entrepreneur
PerioSciences Oral Care is Beauty. From the co-founder & former co-CEO of SkinCeuticals.
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Jeff Galvin!
Join us next time to meet Jeff Galvin!
About Addimmune
Addimmune
Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
Available from
12:00 PM
-
6:00 PM
(US/Pacific)
+1 301-337-2108
Addimmune is a Rockville, Maryland-based, clinical-stage cell and gene therapy company with a line of sight on a functional HIV cure. We have completed a successful FDA-approved Phase I human clinical trial with no serious adverse events and have shown blood markers of efficacy in all seven treated trial participants. An IRB-approved treatment interruption protocol demonstrated the reconstitution of the immune systems of the six who consented to participate. A $50M capital raise is being undertaken in conjunction with 10X Capital, our Wall Street partners with whom we plan a public transaction via de-SPAC in Q1 of next year, to fund our next phase human clinical trial also to begin in Q1 of 2024.
